U.S. FDA Expands Authorization of Pfizer Bivalent COVID-19 Shots in Kids (Reuters) - Pfizer Inc said on Tuesday that the U.S. Food and Drug Administration had expanded the emergency use ...

The U.S. Food and Drug Administration authorized Pfizer's omicron booster shot for kids ... the Pfizer-BioNTech COVID-19 Vaccine, Bivalent," Peter Marks, director of the FDA's Center for Biologics ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least ...

A decision by the FDA on the updated bivalent booster shot is not yet final. This news comes a month after the Centers for ...

Opens in a new tab or window More children under age 5 are now eligible for a COVID ... vaccine and a bivalent booster, FDA said. One month after the bivalent booster, these kids "demonstrated ...

The Food and Drug Administration is considering whether to recommend another bivalent booster shot to prevent COVID-19.

bivalent COVID-19 vaccine as a single booster dose in certain children. The amended authorization is for children six months through four years of age who have completed their initial three-dose ...

Try the tool that will help you invest smarter, faster, and better. This article FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids originally appeared on Benzinga.com ...